TTK Healthcare [TTKHLTCARE] vs Pfizer [PFIZER] Detailed Stock Comparison

TTK Healthcare Ltd

NSE
Loading...

Pfizer Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: TTK Healthcare Ltd wins in 6 metrics, Pfizer Ltd. wins in 14 metrics, with 0 ties. Pfizer Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric TTK Healthcare Ltd Pfizer Ltd. Better
P/E Ratio (TTM) 21.64 25.56 TTK Healthcare Ltd
Price-to-Book Ratio 1.20 5.66 TTK Healthcare Ltd
Debt-to-Equity Ratio 2.47 2.33 Pfizer Ltd.
PEG Ratio -0.56 2.28 Pfizer Ltd.
EV/EBITDA 32.88 22.48 Pfizer Ltd.
Profit Margin (TTM) 7.24% 34.39% Pfizer Ltd.
Operating Margin (TTM) 2.35% 33.17% Pfizer Ltd.
EBITDA Margin (TTM) 2.35% 33.17% Pfizer Ltd.
Return on Equity 7.67% 18.20% Pfizer Ltd.
Return on Assets (TTM) 6.37% 15.63% Pfizer Ltd.
Free Cash Flow (TTM) $-168.16M $6.32B Pfizer Ltd.
Dividend Yield 0.74% 1.27% Pfizer Ltd.
1-Year Return -26.60% -18.08% Pfizer Ltd.
Price-to-Sales Ratio (TTM) 1.57 8.78 TTK Healthcare Ltd
Enterprise Value $7.42B $194.17B Pfizer Ltd.
EV/Revenue Ratio 0.89 7.82 TTK Healthcare Ltd
Gross Profit Margin (TTM) 53.36% 65.15% Pfizer Ltd.
Revenue per Share (TTM) $587 $543 TTK Healthcare Ltd
Earnings per Share (Diluted) $42.53 $186.40 Pfizer Ltd.
Beta (Stock Volatility) 0.17 0.17 TTK Healthcare Ltd

TTK Healthcare Ltd vs Pfizer Ltd. Stock Performance Analysis

Loading Price Chart...

TTKHLTCARE
PFIZER

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TTK Healthcare Ltd-0.84%5.08%-0.46%3.55%-16.02%-9.96%
Pfizer Ltd.-1.09%-2.74%-3.52%-8.08%-9.61%-8.16%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TTK Healthcare Ltd-26.60%-29.56%32.78%-3.63%114.57%214.42%
Pfizer Ltd.-18.08%19.42%-11.38%144.66%248.17%442.50%

Performance & Financial Health Analysis: TTK Healthcare Ltd vs Pfizer Ltd.

MetricTTKHLTCAREPFIZER
Market Information
Market Cap i₹13.01B₹218.82B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,43014,470
90 Day Avg. Volume i7,65218,450
Last Close₹916.75₹4,465.50
52 Week Range₹735.00 - ₹1,398.90₹4,449.20 - ₹5,993.00
% from 52W High-34.47%-25.49%
All-Time High₹1,893.95 (Sep 09, 2024)₹6,451.15 (Sep 02, 2024)
% from All-Time High-51.60%-30.78%
Growth Metrics
Quarterly Revenue Growth0.02%0.20%
Quarterly Earnings Growth-0.37%0.11%
Financial Health
Profit Margin (TTM) i0.07%0.34%
Operating Margin (TTM) i0.02%0.33%
Return on Equity (TTM) i0.08%0.18%
Debt to Equity (MRQ) i2.472.33
Cash & Liquidity
Book Value per Share (MRQ)₹768.05₹841.24
Cash per Share (MRQ)₹425.03₹591.12
Operating Cash Flow (TTM) i₹338.96M₹9.08B
Levered Free Cash Flow (TTM) i₹816.57M₹7.68B
Dividends
Last 12-Month Dividend Yield i0.74%1.27%
Last 12-Month Dividend i₹10.00₹70.00

Valuation & Enterprise Metrics Analysis: TTK Healthcare Ltd vs Pfizer Ltd.

MetricTTKHLTCARE (Apr 26, 2026)PFIZER (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i21.6425.56
Forward P/E iN/A25.15
PEG Ratio i-0.562.28
Price to Sales (TTM) i1.578.78
Price to Book (MRQ) i1.205.66
Market Capitalization
Market Capitalization i₹13.01B₹218.82B
Enterprise Value i₹7.42B₹194.17B
Enterprise Value Metrics
Enterprise to Revenue i0.897.82
Enterprise to EBITDA i32.8822.48
Risk & Other Metrics
Beta i0.170.17
Book Value per Share (MRQ) i₹768.05₹841.24

Financial Statements Comparison: TTK Healthcare Ltd vs Pfizer Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricTTKHLTCARE (2025)PFIZER (2025)
Revenue/Sales i7.98B22.81B
Cost of Goods Sold i3.72B8.13B
COGS % of Revenue i46.6%35.6%
Gross Profit i4.26B14.68B
Gross Margin i53.4%64.4%
Research & Development i1.64MN/A
Operating Income (EBIT) i269.33M6.81B
Operating Margin i3.4%29.9%
EBITDA i1.05B9.13B
EBITDA Margin i13.2%40.0%
Pre-Tax Income i1.08B10.16B
Pre-Tax Income % of Revenue i13.6%44.5%
Income Tax i266.75M2.48B
Income Tax % of Revenue i3.3%10.9%
Net Income (Profit) i816.57M7.68B
Profit Margin i10.2%33.7%

Balance Sheet & Liquidity Metrics

MetricTTKHLTCARE (2025)PFIZER (2025)
Cash & Equivalents i90.06M4.95B
Total Current Assets i11.04B35.13B
Total Current Assets % of Revenue i138.4%154.0%
Total Current Liabilities i2.11B5.70B
Total Current Liabilities % of Revenue i26.4%25.0%
Long-Term Debt i17.73M676.20M
Long-Term Debt % of Revenue i0.2%3.0%
Total Shareholders Equity i10.65B42.17B
Retained Earnings i9.40B24.36B
Retained Earnings % of Revenue i117.9%106.8%
Property, Plant & Equipment i808.99M1.72B

Cash Flow Statement Comparison

MetricTTKHLTCARE (2025)PFIZER (2025)
Operating Cash Flow i338.96M9.08B
Operating Cash Flow % of Revenue i4.2%39.8%
Capital Expenditures i104.56M1.24B
Free Cash Flow i-168.16M6.32B
FCF Margin i-2.1%27.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTTKHLTCAREPFIZER
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i14.13M45.75M
Float Shares i3.25M15.10M
% Held by Insiders i75.64%66.98%
% Held by Institutions i1.89%16.80%
% Held by Public i22.47%16.22%

Dividend Analysis & Yield Comparison: TTK Healthcare Ltd vs Pfizer Ltd.

MetricTTKHLTCAREPFIZER
Last 12-Month Dividend i₹10.00₹70.00
Last 12-Month Dividend Yield i0.74%1.27%
3-Year Avg Annual Dividend i₹13.33₹46.67
3-Year Avg Dividend Yield i0.85%0.58%
3-Year Total Dividends i₹40.00₹140.00
Ex-Dividend DateJul 18, 2025Jul 09, 2025